HKU Scholars Hub: Browsing DSpace

Browsing "Pharmacology and Pharmacy: Patents" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 17 of 17

	Title	Author(s)	Issue Date	Views
	Diazene-Bridge Crown Ether Lithium Compounds And Methods For Their Use	Vanhoutte, Paul Michel Geo Che, Chi Ming So, Kwok Fai Sham, Hiu Tung Iona	2008
	Diazene-bridged crown ether lithium compounds and methods for their use	Vanhoutte, PMGR Che, CM So, KF Sham Iona H.T	2007	115
	Diazene-bridged crown ether lithium compounds and methods for their use	PAUL MICHEL GEORGES VANHOUTTE CHIMING CHE KWOKFAI SO HIUTUNG IONA SHAM	2009	250
	DIAZENE-BRIDGED CROWN ETHER LITHIUM COMPOUNDS AND METHODSFOR THEIR USE	Vanhoutte, PMGR Che, CM So, KF Sham, HI	2006	106
	DIAZENE-BRIDGED CROWN ETHER LITHIUM COMPOUNDS AND METHODSFOR THEIR USE	Vanhoutte, PMGR Che, CM So, KF Sham, HI	2007	149
	Diazene-bridged crown ether lithium compounds and methodsfor their use	Vanhoutte, PMGR Che, CM So, KF Sham HI	2008	170
	LIPOCALIN-2 AS A PROGNOSTIC AND DIAGNOSTIC MARKER FOR HEART AND STROKE RISKS	Xu, A Wang, Y Renneberg, Reinhard Cautherley, GWH Chan, CPY Lehmann, M	2009	160
	LIPOCALIN-2 AS A PROGNOSTIC AND DIAGNOSTIC MARKER FOR HEART AND STROKE RISKS	Xu, A Wang, Y Renneberg, Reinhard Cautherley, GWH Chan, CPY Lehmann, M	2011	118
	Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks	Xu, A Wang, Y Renneberg Reinhard Cautherley, GWH Chan, CPY Lehmann, M	2011	168
	LIPOCALIN-2 AS A PROGNOSTIC AND DIAGNOSTIC MARKER FOR HEART AND STROKE RISKS	Xu, A Wang, Y Renneberg , R Cautherley, GWH Chan, CPY Lehmann, M	2011	514
	Lipocalin-2 As A Prognostic and Diagnostic Marker For Heart And Stroke Risks	Xu, A Wang, Y Renneberg Reinhard Cautherley, GWH Chan, CPY Lehmann, M	2009	150
	Lipocalin-2 As A Prognostic And Diagnostic Marker For Heart And Stroke Risks	Xu, A Wang, Y Renneberg, R Cautherley, GWH Chan, CPY Lehmann, M	2011	139
	Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer Journal:PLoS ONE	Peyser, ND Du, Y Li, H Lui, WYV Xiao, X Chan, TA Grandis, JR	2015	128
	USE OF LIPOCALIN-2 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET	Xu, A Wang, Y Lam, KSL	2008	96
	USE OF LIPOCALIN-2 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET	Xu, A Wang, Y Lam, KSL	2010	109
	USE OF LIPOCALIN-2 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET	Xu, A Wang, Y Lam, KSL	2008	113
	USE OF LIPOCALIN-2 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET	Xu, A Wang, Y Lam, KSL	2010	140

Showing results 1 to 17 of 17